Buda Juice Inc BUDA

$BUDA just got fresh coverage from Roth/MKM. Buy rating, $12 target, that's the same level as its 52-week high. Stock's been as low as $6.25 this year, so Wall Street is pointing at a real round trip if the Texas cold-press playbook expands. MACD just flipped bullish too. 👀

Roth/MKM initiated coverage of Buda Juice, a producer of cold-pressed juices, with a Buy rating and a $12.00 price target, implying significant upside from current levels. Analyst George Kelly highlighted the company's differentiated end-to-end cold-chain supply network and strong sales velocities in its home Texas market as key pillars of the investment thesis. Kelly also pointed to Buda Juice's fresh, unpasteurized products, which are sold at competitive prices in the produce sections of major supermarkets and operate in a relatively uncrowded niche. The company now has capital from its IPO to replicate its Texas strategy in new markets. The $12 target matches the stock's 52-week high, suggesting Roth/MKM sees potential for a recovery to previous highs. The stock has traded as low as $6.25 over the past year, while the new coverage provides investors with a formal Wall Street framework for the company's expansion strategy. $BUDA

$BUDA JUNK

$BUDA Wow, profitable company with accelerating revenue growth and a unique model and no love on this site.

$BUDA Q2 '26 Earnings Results & Recap Buda Juice reported second quarter 2026 revenue of $4.5 million, an increase of 26.4% year over year, while gross margin compressed to 36.6% from 46.7% in the prior-year period.

Jovanotti stepped into a long on $RDGT @ $1.72 $BUDA $CRE $EZGO $IBG

Jovanotti stepped into a long on $BUDA @ $6.80 $CRE $IBG